News | August 10, 2021
Amring Pharmaceuticals launch Isoproterenol Hydrochloride Injection USP
The drug is indicated for mild and transient episodes of heart block
The drug is indicated for mild and transient episodes of heart block
The company has posted net profit / (loss) of Rs.5.33 crores for the 12 months period ended March 31, 2021
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
EMBLAVEOTM is the first and only monobactam/?-lactamase inhibitor combination antibiotic therapy approved by the USFDA
This certification will open new markets for the Kwality Pharma
Alankit will undertake the verification of pending e-KYC enrollments through the Beneficiary Identification System (BIS) platform provided by the National Health Authority (NHA).
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
Subscribe To Our Newsletter & Stay Updated
